Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes
Dapeng Sun, Zhe Sang, Yong Joon Kim, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 18

Showing 18 citing articles:

Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment
Jiewen Wang, Guangbo Kang, Haibin Yuan, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 56
Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics
Lennox Chitsike, Penelope J. Duerksen-Hughes
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 42
Outlook of therapeutic and diagnostic competency of nanobodies against SARS-CoV-2: A systematic review
Hamid Aria, Fatemeh Mahmoodi, Hooria Seyedhosseini Ghaheh, et al.
Analytical Biochemistry (2022) Vol. 640, pp. 114546-114546
Open Access | Times Cited: 25
A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2
Yaochang Yuan, Xiantao Zhang, Ran Chen, et al.
Cell Reports (2021) Vol. 38, Iss. 3, pp. 110256-110256
Open Access | Times Cited: 27
Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, pharmaceutical point of view
Ali Najmeddin, Mina Bahrololoumi Shapourabadi, Mahdi Behdani, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2021) Vol. 1865, Iss. 11, pp. 129974-129974
Open Access | Times Cited: 15
Possible Targets of Pan-Coronavirus Antiviral Strategies for Emerging or Re-Emerging Coronaviruses
Xue Li, Liying Zhang, Si Chen, et al.
Microorganisms (2021) Vol. 9, Iss. 7, pp. 1479-1479
Open Access | Times Cited: 14
The role of single-domain antibodies (or nanobodies) in SARS-CoV-2 neutralization
Arghavan Zebardast, Parastoo Hosseini, Ali Hasanzadeh, et al.
Molecular Biology Reports (2021) Vol. 49, Iss. 1, pp. 647-656
Open Access | Times Cited: 13
Biparatopic sybody constructs neutralize SARS-CoV-2 variants of concern and mitigate emergence of drug resistance
Justin D. Walter, Cedric A. J. Hutter, Alisa A. Garaeva, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 11
Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2
Fred D. Mast, Peter C. Fridy, Natalia E. Ketaren, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 10
Liquid-liquid phase separation in viral infection: from the occurrence and function to treatment potentials
Zheng Cao, Yanhua Yang, Simeng Zhang, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 246, pp. 114385-114385
Closed Access | Times Cited: 1
Impact of New Variants on SAR-CoV-2 Infectivity and Neutralization: A Molecular Assessment of the Alterations in the Spike-Host Protein Interactions
Mary Hongying Cheng, James Krieger, Yufei Xiang, et al.
SSRN Electronic Journal (2021)
Closed Access | Times Cited: 4
Rapid growth in the COVID-19 era
Ye-Rim Lee, Michelle Ng, Kristin Daniel, et al.
MRS Bulletin (2021) Vol. 46, Iss. 9, pp. 847-853
Open Access | Times Cited: 3
Llamanade: an open-source computational pipeline for robust nanobody humanization
Zhe Sang, Yufei Xiang, İvet Bahar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Neutralizing antibody creation technologies: case of SARS-CoV-2
Владимир П. Баклаушев, Ekaterina M. Samoilova, SM Kuznetsova, et al.
Medicine of Extreme Situations (2022), Iss. 2022(4)
Open Access | Times Cited: 1
Dissecting Molecular Determinants of Mutational Escape Mechanisms in the SARS-CoV-2 Spike Protein Complexes with Nanobodies: Atomistic Simulations and Ensemble-Based Deep Mutational Scanning of Protein Stability and Binding Interactions
Gennady M. Verkhivker, Steve Agajanian, Deniz Yaşar Öztaş, et al.
(2021)
Open Access | Times Cited: 1
<i>Llamanade</i>: An Open-Source Computational Pipeline for Robust Nanobody Humanization
Zhe Sang, Yufei Xiang, İvet Bahar, et al.
SSRN Electronic Journal (2021)
Open Access | Times Cited: 1
Deep Mutational Scanning of Dynamic Interaction Networks in the SARS-CoV-2 Spike Protein Complexes: Allosteric Hotspots Control Functional Mimicry and Resilience to Mutational Escape
Gennady M. Verkhivker
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access
Atomistic Simulations and Deep Mutational Scanning of Protein Stability and Binding Interactions in the SARS-CoV-2 Spike Protein Complexes with Nanobodies: Molecular Determinants of Mutational Escape Mechanisms
Gennady M. Verkhivker, Steve Agajanian, Deniz Yaşar Öztaş, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Page 1

Scroll to top